Enzymes random

Equation 11.40 is a special case of a more general mechanism discussed below in which substrates bind to the enzyme randomly. However, to finish discussion of the sequential ordered mechanism, Equation 11.37, we simplify as before, by assuming that binding processes are isotopically insensitive. Equation 11.39 becomes ... 

Cloned HIV-1 reverse tran.scriptasc facilitates the study of Ihe cfTccts of a novel compound on the kinetics of the enzyme. Random screening of chemical inventories by the phannuceutical industry has led to the di.scovery of several NNRTIs of the enzyme. Thc.se inhibitors represent several Miuclurally di.stinct classes. The NNRTIs share a number of common biochemical and pharmacological properties. ... 

Equation 2.28 contains a new term, Km 2, that represents a change in affinity of the enzyme for one substrate once the other substrate is bound. If the mechanism is ordered, the simple relationship Km 2 = Km x Km2 may be applied. For a random mechanism, the value of Km 2 is determined experimentally. Creatine kinase (CK) is an example of this type of enzyme. Creatinine and ATP bind to the enzyme randomly in nearby, but independent binding sites. 

Recently, the use of Hpase enzymes to iateresterify oils has been described (23). In principle, if a 1,3-speciftc Hpase is used, the fatty acid ia the 2 position should remain unchanged and the randomization occur at the terminal positions. However, higher temperatures, needed to melt soHd fats, may cause a 1,2-acyl shift and fatty acids are scrambled over all positions. 

Films or membranes of silkworm silk have been produced by air-drying aqueous solutions prepared from the concentrated salts, followed by dialysis (11,28). The films, which are water soluble, generally contain silk in the silk I conformation with a significant content of random coil. Many different treatments have been used to modify these films to decrease their water solubiUty by converting silk I to silk II in a process found usehil for enzyme entrapment (28). Silk membranes have also been cast from fibroin solutions and characterized for permeation properties. Oxygen and water vapor transmission rates were dependent on the exposure conditions to methanol to faciUtate the conversion to silk II (29). Thin monolayer films have been formed from solubilized silkworm silk using Langmuir techniques to faciUtate stmctural characterization of the protein (30). ResolubiLized silkworm cocoon silk has been spun into fibers (31), as have recombinant silkworm silks (32). 

Several clinical trials have been conducted with streptokinase adrninistered either intravenously or by direct infusion into a catheterized coronary artery. The results from 33 randomized trials conducted between 1959 and 1984 have been examined (75), and show a significant decrease in mortaUty rate (15.4%) in enzyme-treated patients vs matched controls (19.2%). These results correlate well with an ItaUan study encompassing 11,806 patients (76), in which the overall reduction in mortaUty was 19% in the streptokinase-treated group, ie, 1.5 million units adrninistered intravenously, compared with placebo-treated controls. The trial also shows that a delay in the initiation of treatment over six hours after the onset of symptoms nullifies any benefit from this type of thrombolytic therapy. Conversely, patients treated within one hour from the onset of symptoms had a remarkable decrease in mortaUty (47%). The benefits of streptokinase therapy, especially in the latter group of patients, was stiU evident in a one-year foUow-up (77). In addition to reducing mortahty rate, there was an improvement in left ventricular function and a reduction in the size of infarction. Thus early treatment with streptokinase is essential. 

Anistreplase has a considerably longer a half-life than streptokinase, ie, 90 min compared to 20 min (87,88). Moreover, it does not require prolonged infusion to achieve its thrombolytic effects. Anistreplase was found to be highly effective after a single intravenous dose of 30 units over a 5-min period compared to a 60-min infusion of 1.5 million units of streptokinase (89—94). In direct comparative studies, anistreplase was as effective as intracoronary (95,96) and intravenously (96—100) adrninistered streptokinase. In a randomized, double-blind, placebo-controUed study (AIMS trial) with 1004 patients given this modified enzyme, the 30-day mortaUty rate was 12.2% for patients receiving placebo, compared to 6.4% for patients who received 30 units of anistreplase intravenously within six hours of the onset of symptoms (101). 

Protein engineering is now routinely used to modify protein molecules either via site-directed mutagenesis or by combinatorial methods. Factors that are Important for the stability of proteins have been studied, such as stabilization of a helices and reducing the number of conformations in the unfolded state. Combinatorial methods produce a large number of random mutants from which those with the desired properties are selected in vitro using phage display. Specific enzyme inhibitors, increased enzymatic activity and agonists of receptor molecules are examples of successful use of this method. 

All of the structures shown in Figures 7.2 and 7.3 are D-configurations, and the D-forms of monosaccharides predominate in nature, just as L-amino acids do. These preferences, established in apparently random choices early in evolution, persist uniformly in nature because of the stereospecificity of the enzymes that synthesize and metabolize these small molecules. 

An example of a random, single-displacement mechanism is seen in the enzyme creatine kinase, a phosphoryl-transfer enzyme that uses ATP as a phosphoryl... 

Partial hydrolysis of a peptide can be carried out either chemically with aqueous acid or enzymatically. Acidic hydrolysis is unselective and leads to a more or less random mixture of small fragments, but enzymatic hydrolysis is quite specific. The enzyme trypsin, for instance, catalyzes hydrolysis of peptides only at the carboxyl side of the basic amino acids arginine and lysine chymotrypsin cleaves only at the carboxyl side of the aryl-substituted amino acids phenylalanine, tyrosine, and tryptophan. 

---